Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 DiabetesJune 7, 2026
Web3 Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 DiabetesJune 7, 2026 HDV Insulin Lispro (HDV-LIS) met A1C non-inferiority at weeks 12 and 25, confirming comparable glycemic control to insulin lispro (LIS)…
